Talazoparib 0.25 mg, 1 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 0.25 mg, 1 mg

Reference Brands: Talzenna (USA/EU)

Category: Oncology Cancer Care

Talazoparib is a Oncology Cancer Care product available as Capsules in strengths 0.25 mg, 1 mg. It corresponds to the reference brand Talzenna (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Talazoparib tosylate is a targeted anticancer medication belonging to the class of poly ADP-ribose polymerase (PARP) inhibitors. It is used for the treatment of adults with HER2-negative, locally advanced or metastatic breast cancer who carry germline BRCA1 or BRCA2 gene mutations. It is also used in combination with enzalutamide for certain patients with metastatic castration-resistant prostate cancer that have homologous recombination repair (HRR) gene mutations and whose disease has progressed despite testosterone-lowering therapy.

Talazoparib works by blocking the PARP enzyme, which plays a key role in repairing damaged DNA inside cells. Cancer cells that already have defects in DNA repair pathways, such as BRCA-mutated cells, become unable to repair genetic damage when PARP is inhibited, leading to cell death. This mechanism makes talazoparib an example of precision oncology based on genetic profiling. It is administered orally and marketed under the brand name Talzenna by Pfizer. Clinical studies have shown meaningful benefit in selected patients, and treatment is given under oncology specialist supervision with regular safety monitoring.